My Short Biography:
Heinrich R. Schelbert is a Distinguished Professor in the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. His research has focused on developing and validating noninvasive radionuclide imaging techniques for the study of cardiovascular function in humans. Major accomplishments include the discovery of the PET perfusion metabolism mismatch as a marker of myocardial viability and the development and validation of measurements of myocardial blood flow with 13N-ammonia and PET. He is a two-times recipient of the Georg von Hevesy Prize by the World Federation of Nuclear Medicine and Biology, of the George de Hevesy Nuclear Medicine Pioneer Award by the Society of Nuclear Medicine and Molecular Imaging, the Distinguished Scientific Achievement Award by the American Heart Association, the Lifetime Achievement Award by the American College of Cardiology and the Distinguished Service Award by the American Society of Nuclear Cardiology. From 2004 to 2011, he served as the Editor-in-Chief of the Journal of Nuclear Medicine.
Non-invasive Method, Echocardiogram, CMR, CT and Nuclear Medicine
This website is optimized for Chrome and Internet Explorer 11.